CDKN2B anticorps (C-Term)
Aperçu rapide pour CDKN2B anticorps (C-Term) (ABIN2619062)
Antigène
Voir toutes CDKN2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Recognizes endogenous levels of p15 INK4b protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human p15 INK4b.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ICC (1:100 - 1:500), IF, IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Autre désignation
- CDKN2B / p15 INK4b
-
Sujet
-
Name/Gene ID: CDKN2B
Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15 -
ID gène
- 1030
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases
Antigène
-